(Q45358610)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469985%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

Kaposi's sarcoma herpesvirus lytic replication compromises apoptotic response to p53 reactivation in virus-induced lymphomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469985%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469985%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Pirjo Laakkonen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469985%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Päivi M Ojala

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469985%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

G Sarek

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469985%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

L Ma

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469985%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

J Enbäck

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469985%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

A Järviluoma

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469985%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

J Haas

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469985%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

A Gessain

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469985%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

P J Koskinen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469985%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

language of work or name

English

0 references

publication date

2 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469985%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469985%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469985%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469985%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

1091-1098

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469985%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2012.118

27 January 2020

exact match

0 references

cites work

Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

New approaches to the treatment of human herpesvirus 8-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Regulation of p53 stability by Mdm2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Establishment and characterization of EBV-positive and EBV-negative primary effusion lymphoma cell lines harbouring human herpesvirus type-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Human herpesvirus-8 ORF K8.1 gene encodes immunogenic glycoproteins generated by spliced transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Effects of NFkappaB activation on KSHV latency and lytic reactivation are complex and context-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

NF-kB inhibition as a strategy to enhance etoposide-induced apoptosis in K562 cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains hypoxia response elements: relevance to lytic induction by hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Combined chemotherapy including high-dose methotrexate in KSHV/HHV8-associated primary effusion lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Functional p53 signaling in Kaposi's sarcoma-associated herpesvirus lymphomas: implications for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Hypoxia enhances the phosphorylation and cytotoxicity of ganciclovir and zidovudine in Kaposi's sarcoma-associated herpesvirus infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Human gammaherpesvirus cytokines and chemokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Application of active and kinase-deficient kinome collection for identification of kinases regulating hedgehog signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

KSHV reactivation from latency requires Pim-1 and Pim-3 kinases to inactivate the latency-associated nuclear antigen LANA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Synthesis, kinase inhibitory potencies, and in vitro antiproliferative evaluation of new Pim kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

KSHV infection and the pathogenesis of Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

KSHV viral cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Prognostic Factors and Outcome of Human Herpesvirus 8–Associated Primary Effusion Lymphoma in Patients With AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Antiviral activity and mechanism of action of ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

A preclinical and clinical overview of the nucleotide-based antiviral agent cidofovir (HPMPC).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Successful secondary prophylaxis for primary effusion lymphoma with human herpesvirus 8 therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.118

31 March 2020

Identifiers

DOI

10.1038/ONC.2012.118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469985%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

27 January 2020

1011860552

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469985%20AND%20SRC:MED&resulttype=core&format=json